Immunotherapy for head and neck cancer: where do we go from here?

Eric C Ko,Glenn J Hanna

doi:10.2217/imt-2023-0191

Immunotherapy for head and neck cancer: where do we go from here?

Eric C Ko, Glenn J Hanna

https://doi.org/10.2217/imt-2023-0191

Copy DOI

Export

Save

Cite

Journal: Immunotherapy

Publication Date: Nov 27, 2023

Affiliation: University of Massachusetts Chan Medical School, Dana-Farber Cancer Institute, Harvard University

#Optimize Combination Therapy #Immunotherapy For Cancer #Neck Cancer #Improve Patient Selection #Recent Trials #Patient Selection #Combination Therapy

Abstract
Full-Text
Similar Papers

Abstract

Listen

Tweetable abstract Immunotherapy for head and neck cancer shows promising new directions - and challenges ahead. What can we learn from recent trials to improve patient selection and optimize combination therapy?

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Immunotherapy

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Immunotherapy for head and neck cancer: where do we go from here?